For greatest resolution of the ademne derivatives, we used an ion-pairing reversed-phase method with gradient elution (17) . Buffer A consisted of tetrabutylammonium hydrogen sulfate, 2 mmol/L, and ammonium dihydrogen phosphate, 2.5 mmolJL, mixed with acetonitrile (50 mLIL). Buffer B contained the same components but the
was increased to 75 mmol/L and the proportion of acetonitrile was increased to 150 mLIL. Both buffers were adjusted to pH 5.0 with anunonium hydroxide. After equilibration of the RP-8 column with buffer A, samples were injected and chromatographic separation and elution of the adenine derivatives was started with 100% buffer A (4 mm), followed by a linear gradient from 100% buffer A to 100% buffer B (2 mm), and finished with 100% buffer B (4 mm). The column was then reequilibrated with 100% buffer A (8 mm). Flow rate was 1 mL/min. Ultraviolet absorbance of the eluted 
Separationof Adenine Derivativesby HPLC
The efficiency of the ion-pairing reversed-phase method in separating ademne derivatives is shown in Sensitivity, Linearity, and Reproducibilityof Fluorescence Detection Figure 5 shows the chromatograms of a human plasma sample containing PMEA at an original concentration (before derivatization) of 10 mg/L. Fluorescence detection of EPMEA after reaction with chioroacetaldehyde proved to be at least 15-fold more sensitive than absorbance detection of the original compound (PMEA). PMEA, HPMPA, and FPMPA were detectable at amounts as low as 20 pmol (signal-to-noise ratio of 3) when an emission filter of 425 nm and excitation at 254 nm were used. In contrast, the detection limit of PMEA, HPMPA, and FPMPA by their absorbance at 260 nm was 330 pmol.
Response of the fluorescence detector was linear with
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ELUTION TIME (mm) jected within the range of 0.02-3 nmol. PMEA, HPMPA, or FPMPA was added to blank human plasma samples at various concentrations.
Extracts containing high concentrations of compound were diluted before HPLC analysis to prevent overloading of the system, which would lead to ineffective response of the fluorescence detector. Calibration curves for PMEA, HP-MPA, and FPMPA in human plasma proved linear (r2 >0.9998) within a concentration range from 0.25 to 4000 janol/L (data not shown).
In the recovery study to investigate loss of PMEA, HPMPA, or FPMPA from plasma during the extraction procedure (i.e., precipitation of plasma proteins followed by neutralization with amine/Freon), analytical recovery was 86-105%, showing that our extraction procedure is highly efficient ( 
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Values calculated from data obtained from five Independent determinations. N.D., not determined. 4.9 per liter in plasma, which is 30-fold below the detection 3.5 3.3 3.4 limit by the conventional absorbance assay and at least 2.6 2.4 N.D. five-to 25-fold lower than the antivirally effective concentrations of these drugs. Therefore, the procedure described here should be useful to monitor drug concentrations in plasma when developing therapeutic protocols for PMEA,HPMPA, and FPMPA.
The pharmacokinetics of PMEA in monkeys and cats can be readily followed with the fluorescence method.
The terminal half4ife of 45 mm for PMEA in rhesus monkeys agrees previous data showing a half-life of 1-3 h upon intravenous bolus administration of PMEA at 100 mg/kg (13) . Similarly, our results on the clearance of PMEA in cats are consistent with previous data (11) .
Formation of fluorescent 1, N 6-ethenoadenine derivatives after reaction with chioroacetaldehyde is a general feature of adenine-based compounds. Therefore, natural ademne derivatives present in plasma extracts could theoretically interfere with the fluorescence detection of PMEA, HPMPA, and FPMPA. Consequently, we used an ion-pairing reversed-phase chromatographic method that separates PMEA, HPMPA, and FPMPA from free adenine or adenosine, so that none of the naturally occurring adenine derivatives in plasma interfered with the detection of the acyclic nucleoside phosphonates. Moreover, the high amounts of AMP in samples that had undergone substantial hemolysis did not interfere with the determination of PMEA. Although the formation of fluorescent adenine and adenosine derivatives after reaction with chloroacetaldehyde has been studied in detail (22) (23) (24) (25) and several applications for the analysis of natural adenine derivatives in biological samples have been reported (26) (27) (28) (29) (30) , the chloroacetaldehyde-based method has not been widely applied in pharmacological or pharmacokinetic studies on adenine nucleoside analogs (31). We have now demonstrated that reaction of adenine derivatives with chioroacetaldehyde can be used to monitor plasma concentrations of the antivirally active acycic nucleoside phosphonates HPMPA, PMEA, and FPMPA. The fluorescence method described here for serum and plasma samples may be applicable to other biological systems as well (e.g., urine samples and cell extracts). This means that our assay may be useful in establishing both the pharmacokinetic and pharmacological properties of these promising antiviral compounds.
